LARIMAR THERAPEUTICS, INC. Gain (Loss) on Disposition of Assets
LARIMAR THERAPEUTICS, INC. (LRMR) reported Gain (Loss) on Disposition of Assets of $1.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-14.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2023-03-14
- LARIMAR THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2021-12-31 was $0.00.
- LARIMAR THERAPEUTICS, INC. gain (loss) on disposition of assets for the quarter ending 2021-09-30 was $6.00K.
- LARIMAR THERAPEUTICS, INC. gain (loss) on disposition of assets for fiscal 2021 was $1.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $6.00K derived: sum of 2 quarters · filed 2023-03-14 | $1.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$5.00K 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |